NeuBase Therapeutics

0 followers


NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines that can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.

Industries

Headquarters

Stage

Employees

Links

Org chart

Dietrich A. Stephan
CEO, Founder, & Director

Dietrich A. Stephan

Collapse
Sandra Rojas-Caro
Chief Medical Officer
Ranajoy Sarkar
Senior Vice President And Head, Corporate Strategy & Business Development
John J. Thomas
Sr. Director, Analytical Development
Jonathan Leung
Senior Director, Pharmaceutical Quality
Eric Richman
Director
Jessica Balogh
Executive Assistant to Chairman & CEO
Sally Edmonds
Director, Human Resources
Jeremy Gleaton
Principal Scientist
Lydia(Lyuqin) Chen
Senior Scientist
William Riedl
Principal Scientist
Barry Badeau
Senior Scientist
Chelsea Martinez
Senior Scientist (Peptide Nucleic Acid Chemistry)
Kayla Williams
Associate Scientist
Lindsey Spiker
Scientist I
Nathan T.
Senior Scientist
Steven Murphy
Scientist I